Conde-AgudeloARosas-BermúdezAKafury-GoetaAC. Effects of birth spacing on maternal health: a systematic review. Am. J. Obstet. Gynecol.196(4), 297–308 (2007).
2.
Conde-AgudeloARosas-BermúdezAKafury-GoetaAC. Birth spacing and risk of adverse perinatal outcomes: a meta-analysis. JAMA295(15), 1809–1823 (2006).
3.
US Department of Health and Human Services, Office of Disease Prevention and Health Promotion.Healthy People 2020.Washington, DC. www.healthypeople.gov
4.
GrayRHCampbellOMZacurHLabbokMHMacRaeSL. Postpartum return of ovarian activity in non-breastfeeding women monitored by urinary assays. J. Clin. Endocrinol. Metab.64, 645–650 (1987).
5.
CDC.The United States Medical Eligibility Criteria for Contraceptive Use (2010). www.cdc.gov
6.
ACOG Practice Bulletin 121: long-acting reversible contraception: implants and intrauterine devices. Obstet. Gynecol.118(1), 184–196 (2011).
7.
SecuraGMMaddenTMcNicholasC. Provision of no-cost, long-acting contraception and teenage pregnancy. N. Engl. J. Med.371(14), 1316–1323 (2014).
8.
Thiel de BocangeraTChangRHowellMDarneyP. Interpregnancy intervals: impact of postpartum contraceptive effectiveness and coverage. Am. J. Obstet. Gynecol.210(4), 311.e1–311.e8 (2014).
9.
TocceKMSheederJLTealSB. Rapid repeat pregnancy in adolescents: do immediate postpartum contraceptive implants make a difference?Am. J. Obstet. Gynecol.206(6), 481.e1–481.e7 (2012).
10.
LuchowskiATAndersonBLPowerMLEspeyESchulkinJ. Obstetrician–gynecologists and contraception: practice and opinions about use of IUDs in nulliparous women, adolescents and other patient populations. Contraception89(6), 572–527 (2014).
11.
WhiteKPotterJHopkinsKGrossmanD. Variation in postpartum contraceptive method use: results from the Pregnancy Risk Assessment Monitoring System (PRAMS). Contraception89(1), 57–62 (2014).
12.
RodriguezMEvansMEspeyE. Advocating for immediate postpartum LARC: increasing access, improving outcomes, and decreasing cost. Contraception90(5), 468–471 (2014).
13.
HanLTealSSheederJTocceK. Preventing repeat pregnancy in adolescents: is immediate postpartum insertion of the contraceptive implant cost effective?Am. J. Obstet. Gynecol.211(1), 24.e1–24.e7 (2014).
14.
BritoMBFerrianiRAQuintanaSMYazlleMESilva de SáMFVieiraCS. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception80(6), 519–526 (2009).
15.
DarneyPPatelARosenKShapiroLKaunitzA. Safety and efficacy of a single-rod etonogestrel implant (Implanon); results from 11 international clinical trials. Fertil. Steril.91(5), 1646–1653 (2009).
16.
IrelandLGoyalVRakerCMurrayAAllenR. The effect of immediate postpartum compared with delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding. Contraception90(3), 253–258 (2014).
17.
OrtizMECroxattoHB. Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action. Contraception75(6 Suppl.), S16–S30 (2007).
18.
PeipertJFZhaoQAllsworthJE. Continuation and satisfaction of reversible contraception. Obstet. Gynecol.117(5), 1105–1113 (2011).
19.
ChenBAReevesMFCreininMDSchwarzEB. Postplacental or delayed levonorgestrel intrauterine device insertion and breast-feeding duration. Contraception84(5), 499–504 (2011).
20.
KappNCurtisK. Intrauterine device insertion during the postpartum period: a systematic review. Contraception80(4), 327–336 (2009).
21.
WhitakerALEndresLKMistrettaSQGilliamML. Postplacental insertion of the levonorgestrel intrauterine device after cesarean delivery vs. delayed insertion: a randomized controlled trial. Contraception89(6), 534–539 (2009).
22.
KaislasuoJSuhonenSGisslerMLähteenmäkiPHeikinheimoO. Intrauterine contraception: incidence and factors associated with uterine perforation – a population-based study. Hum. Reprod.27(9), 2658–2663 (2012).
23.
GomezAMFuentesLAllinaA. Women or LARC first? Reproductive autonomy and the promotion of long-acting reversible contraceptive methods. Perspect. Sex. Reprod. Health46(3), 171–175 (2014).
24.
WinnerBPeipertJFZhaoQ. Effectiveness of long-acting reversible contraception. N. Engl. J. Med.366(21), 1998–2007 (2012).